Citadel Advisors’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$972K Buy
77,900
+47,300
+155% +$632K ﹤0.01% 7720
2025
Q4
$525K Sell
30,600
-119,200
-80% -$1.21M ﹤0.01% 8916
2025
Q3
$788K Sell
149,800
-63,800
-30% -$286K ﹤0.01% 8061
2025
Q2
$893K Sell
213,600
-41,360
-16% -$259K ﹤0.01% 7355
2025
Q1
$3.58M Buy
254,960
+197,670
+345% +$3.47M ﹤0.01% 4454
2024
Q4
$1.61M Buy
+57,290
New +$4.91M ﹤0.01% 6080

Other funds holding MSTZ

Citadel Advisors's MSTZ Position: Q1 2026 in Review

Citadel Advisors sold out of T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) in Q1 2026, closing a stake of 13,364 shares — an estimated $179K sold.

Citadel Advisors first reported a position in MSTZ in Q1 2025 and held it in 4 quarters. The position peaked at $4.38M in Q1 2025. 16 funds tracked by Wall St. Rank hold MSTZ as of Q1 2026.

  • Citadel Advisors reported no remaining T-Rex 2X Inverse MSTR Daily Target ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 13,364 T-Rex 2X Inverse MSTR Daily Target ETF shares in Q1 2026, an estimated $179K.
  • Citadel Advisors first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q1 2025 and held it in 4 quarters.
  • Citadel Advisors's T-Rex 2X Inverse MSTR Daily Target ETF position peaked at $4.38M in Q1 2025.
  • 16 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.